BETH BAKER: Open Payments
NPI 1295458073 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$103 in 5 payments from 3 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $103
Food & beverage: $103
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $46 |
| Otsuka America Pharmaceutical, Inc. | 2 | $31 |
| Gilead Sciences, Inc. | 1 | $26 |
Products named: INGREZZA, REXULTI.
Industry payments across IN — which companies pay providers there.
